T0	Participants 70 89	high-risk patients.
T1	Participants 158 179	fat embolism syndrome
T2	Participants 246 290	high-risk patients with long-bone fractures.
T3	Participants 410 474	corticosteroid- (0 of 21) and placebo-treated patients (9 of 41)
T4	Participants 1033 1084	patients at high risk for the fat embolism syndrome